Fetal Lower Urinary Tract Obstruction: An Update

Russell S. Miller*
Carmen and John Thain Center for Prenatal Pediatrics, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 10333
Abstract HTML Views: 2076
PDF Downloads: 1815
ePub Downloads: 718
Total Views/Downloads: 14942
Unique Statistics:

Full-Text HTML Views: 4863
Abstract HTML Views: 1077
PDF Downloads: 1175
ePub Downloads: 519
Total Views/Downloads: 7634

Creative Commons License
© Russell S. Miller ; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, 622 West 168th Street, PH 16-66, New York, New York 10032, USA; Tel: (212) 305-6293; Fax: (212) 342-2717; E-mail:


Fetal lower urinary tract obstruction [LUTO] represents a rare, heterogeneous group of uropathies involving mechanical or functional blockage at the bladder outlet of varying severity. While ultrasound is a fair screening tool for the antenatal detection of this condition, it cannot reliably determine the underlying etiology of LUTO presentations. Sonographic assessment of renal appearance and amniotic fluid volume, as well as urinary analyte analysis, are the most useful predictors of preserved renal function in fetal LUTO, although they, too, are limited in their ability to predict outcomes on an individual basis. Animal models suggest that obstructive uropathy likely causes irreparable damage to the renal and urinary collecting system injury early in pregnancy. When LUTO is associated with abnormal amniotic fluid volume, long-standing oligohydramnios may result in lethal pulmonary hypoplasia. Data evaluating the efficacy of vesicoamniotic shunt therapy for the treatment of fetal LUTO are inconclusive. While vesicoamniotic shunting may modify disease lethality by restoring fluid volume, renal and other genitourinary benefits are minimal if not altogether absent, arguably supporting the belief that bladder decompression is being performed after irreversible injury has already been sustained.

Keywords: Fetal urinary tract obstruction, oligohydramnios, prenatal diagnosis, prenatal ultrasonography, posterior urethral valves, urinary analytes, vesicoamniotic shunt.